AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK
AstraZeneca also played a critical role in the global response to COVID-19.
AstraZeneca also played a critical role in the global response to COVID-19.
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Launch of 20 new medicines expected by 2030
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Evinova will operate as a separate health-tech business within AstraZeneca
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
Subscribe To Our Newsletter & Stay Updated